Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Abstract

Background Glucagon-like peptide 1 (GLP-1) has been proposed as a treatment for type 2 diabetes. We have investigated the long-term effects of continuous administration of this peptide hormone in a 6-week pilot study. Methods 20 patients with type 2 diabetes were alternately assigned continuous subcutaneous infusion of GLP-1 (n=10) or saline (n=10) for 6 weeks. Before (week 0) and at weeks 1 and 6, they underwent beta-cell function tests (hyperglycaemic clamps), 8 h profiles of plasma glucose, insulin, C-peptide, glucagon, and free fatty acids, and appetite and side-effect ratings on 100 mm visual analogue scales; at weeks 0 and 6 they also underwent dexascanning, measurement of insulin sensitivity (hyperinsulinaemic euglycaemic clamps), haemoglobin A(1c), and fructosamine. The primary endpoints were haemoglobin A(1c) concentration, 8-h profile of glucose concentration in plasma, and beta-cell function (defined as the first-phase response to glucose and the maximum insulin secretory capacity of the cell). Analyses were per protocol. Findings One patient assigned saline was excluded because no veins were accessible. In the remaining nine patients in that group, no significant changes were observed except an increase in fructosamine concentration (p=0.0004). In the GLP-1 group, fasting and 8 h mean plasma glucose decreased by 4.3 mmol/L and 5.5 mmol/L (p Interpretation GLP-1 could be a new treatment for type 2 diabetes, though further investigation of the long-term effects of G…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)07952-7

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 37 references

Cited by

See all 1,297

Metadata

Authors
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J.
Affiliations
  • University of Copenhagen (DK)
  • Hvidovre Hospital (DK)
Corresponding author
Zander, Mette
Venue
The Lancet
Publisher
Elsevier BV
Published
2002-03
Volume
359
Issue
9309
Pages
824-830
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2143014102
Cited by
1,297
References
37
Citations by year
2026: 16 · 2025: 20 · 2024: 32 · 2023: 19 · 2022: 23 · 2021: 30 · 2020: 18 · 2019: 35 · 2018: 34 · 2017: 41 · 2016: 40 · 2015: 50 · 2014: 62 · 2013: 69 · 2012: 76
FWCI
38.90
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Diabetesforeningen
  • Sundhed og Sygdom, Det Frie Forskningsråd
  • Novo Nordisk Fonden
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
glucagon-like peptide-1, type 2 diabetes, glycemic control, insulin sensitivity, beta-cell function, continuous subcutaneous infusion, hyperinsulinemic-euglycemic clamp, hyperglycaemic clamp, free fatty acids, gastric emptying, appetite, HbA1c, fructosamine, weight loss, insulin secretion, glucagon
MeSH terms
Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Fasting, Female, Glucagon, Humans, Insulin, Islets of Langerhans, Male, Middle Aged, Peptide Fragments, Pilot Projects, Protein Precursors, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. https://app.cochat.ai/papers/10.1016/s0140-6736(02)07952-7
The paper
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002). Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. The Lancet. https://doi.org/10.1016/s0140-6736(02)07952-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.